Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Micro-X Limited (MCRXF)

Compare
0.0550
-0.0350
(-38.89%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for MCRXF
  • Previous Close 0.0000
  • Open 0.0700
  • Bid 0.0620 x --
  • Ask --
  • Day's Range 0.0700 - 0.0700
  • 52 Week Range 0.0300 - 0.1100
  • Volume 10,000
  • Avg. Volume 3,363
  • Market Cap (intraday) 36.53M
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Micro-X Limited designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. The company offers carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for full medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; ARGUS for transforming stand-off imaging; Checkpoints, a modular passenger self-screening checkpoint for airports; and Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.

www.micro-x.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: MCRXF

View More

Performance Overview: MCRXF

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

MCRXF
45.00%
S&P/ASX 200 [XJO] (^AXJO)
4.60%

1-Year Return

MCRXF
35.29%
S&P/ASX 200 [XJO] (^AXJO)
0.41%

3-Year Return

MCRXF
31.25%
S&P/ASX 200 [XJO] (^AXJO)
3.46%

5-Year Return

MCRXF
31.25%
S&P/ASX 200 [XJO] (^AXJO)
42.39%

Compare To: MCRXF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MCRXF

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    25.05M

  • Enterprise Value

    26.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.35

  • Price/Book (mrq)

    7.10

  • Enterprise Value/Revenue

    3.97

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -76.33%

  • Return on Assets (ttm)

    -51.45%

  • Return on Equity (ttm)

    -134.23%

  • Revenue (ttm)

    14.13M

  • Net Income Avi to Common (ttm)

    -10.78M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.39M

  • Total Debt/Equity (mrq)

    84.93%

  • Levered Free Cash Flow (ttm)

    -8.83M

Research Analysis: MCRXF

View More

Company Insights: MCRXF

Research Reports: MCRXF

View More